Chronic cocaine causes age-dependent increases in risky choice in both males and females.


Journal

Behavioral neuroscience
ISSN: 1939-0084
Titre abrégé: Behav Neurosci
Pays: United States
ID NLM: 8302411

Informations de publication

Date de publication:
Jun 2022
Historique:
pubmed: 18 3 2022
medline: 24 5 2022
entrez: 17 3 2022
Statut: ppublish

Résumé

Individuals who use cocaine exhibit maladaptive decision-making, overweighting rewards, and underweighting potential risks. We previously showed that chronic cocaine self-administration in young adult male rats causes long-lasting increases in risk taking. The present study expanded upon these findings to determine whether effects of cocaine on risk taking depend on the route of cocaine administration and extend to females. To address the former question, rats in Experiment 1 were trained on the Risky Decision-making Task (RDT), received passively administered cocaine, and were retested in the RDT. Surprisingly, passive cocaine had no effect on risk taking. Experiment 2 determined whether cocaine self-administration increases risk taking in females in a manner comparable to males. Males and females were trained in the RDT, underwent cocaine self-administration, and were retested in the RDT. Unexpectedly, cocaine self-administration had no effect on risk taking in either sex. Because Experiments 1 and 2 involved cocaine exposure at a considerably older age than in previous work, Experiments 3 and 4 determined if cocaine effects on risk taking depend on the age of exposure. Rats began cocaine self-administration at postnatal (PN) day 77 (Experiment 3) or passive cocaine injections starting on PN day 63 (Experiment 4) and were tested in the RDT 3 weeks after cocaine cessation. In these experiments, cocaine increased risk taking in both sexes. These results reveal a limited time window during young adulthood of vulnerability to the effects of chronic cocaine on risk taking. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

Identifiants

pubmed: 35298207
pii: 2022-43404-001
doi: 10.1037/bne0000509
pmc: PMC9346435
mid: NIHMS1825631
doi:

Substances chimiques

Cocaine I5Y540LHVR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-263

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA024671
Pays : United States
Organisme : NIDA NIH HHS
ID : R00 DA041493
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA036534
Pays : United States
Organisme : NIH HHS
Pays : United States
Organisme : NIDA NIH HHS
ID : K99 DA041493
Pays : United States

Références

J Neurosci. 2003 Apr 15;23(8):3531-7
pubmed: 12716962
Neuropsychopharmacology. 2014 Mar;39(4):955-62
pubmed: 24145852
Neuropsychopharmacology. 2002 Feb;26(2):183-90
pubmed: 11790514
Cogn Affect Behav Neurosci. 2019 Dec;19(6):1404-1417
pubmed: 31342271
Methods Mol Biol. 2019;2011:79-92
pubmed: 31273694
Addict Biol. 2020 May;25(3):e12738
pubmed: 30848014
Neuropsychopharmacology. 2009 Sep;34(10):2208-17
pubmed: 19440192
Drug Alcohol Depend. 2005 Apr 4;78(1):83-90
pubmed: 15769561
Front Neuroendocrinol. 2008 Jan;29(1):36-47
pubmed: 17904621
Behav Neurosci. 2014 Aug;128(4):419-29
pubmed: 24841739
eNeuro. 2019 Aug 20;6(4):
pubmed: 31387878
Psychopharmacology (Berl). 1999 May;144(1):77-82
pubmed: 10379627
Drug Alcohol Depend. 2012 Jun 1;123(1-3):84-90
pubmed: 22079143
Alcohol Clin Exp Res. 2014 Jun;38(6):1622-9
pubmed: 24689661
Drug Alcohol Depend. 2005 Feb 14;77(2):169-75
pubmed: 15664718
Pharmacol Biochem Behav. 2009 Nov;94(1):163-8
pubmed: 19698740
Am J Addict. 2012 May-Jun;21(3):263-7
pubmed: 22494229
Neuropsychopharmacology. 2021 Feb;46(3):603-613
pubmed: 32919406
Neuropharmacology. 2009;56 Suppl 1:63-72
pubmed: 18692512
Psychon Bull Rev. 2004 Aug;11(4):742-7
pubmed: 15581127
Psychopharmacology (Berl). 2015 Oct;232(19):3573-83
pubmed: 26156635
Brain Res. 2007 Jul 9;1157:1-10
pubmed: 17544385
Behav Neurosci. 2007 Jun;121(3):543-9
pubmed: 17592945
Neuron. 2008 Jul 31;59(2):288-97
pubmed: 18667156
Psychopharmacology (Berl). 2014 Dec;231(23):4489-501
pubmed: 24800898
Neuropharmacology. 2018 Sep 1;139:205-216
pubmed: 30009836
Psychol Addict Behav. 2005 Jun;19(2):148-57
pubmed: 16011385
J Neurosci Res. 2017 Jan 2;95(1-2):260-269
pubmed: 27870448
Psychopharmacology (Berl). 2000 Feb;148(2):196-200
pubmed: 10663435
Psychopharmacology (Berl). 1999 Mar;143(1):47-53
pubmed: 10227079
eNeuro. 2017 Feb 6;4(1):
pubmed: 28197550
J Cogn Neurosci. 2012 Jan;24(1):196-211
pubmed: 21916564
Neuropsychopharmacology. 2012 Nov;37(12):2605-14
pubmed: 22871910
Behav Pharmacol. 2009 Sep;20(5-6):400-5
pubmed: 19675455
Pharmacol Biochem Behav. 1984 Jul;21(1):133-6
pubmed: 6463085
Drug Alcohol Depend. 2007 Sep 6;90(1):2-11
pubmed: 17367959
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jan;2(1):94-103
pubmed: 28164168
J Neurosci. 2011 Jun 8;31(23):8625-33
pubmed: 21653866
Ann N Y Acad Sci. 2007 Dec;1121:598-609
pubmed: 17846156
J Clin Exp Neuropsychol. 2009 Aug;31(6):706-19
pubmed: 19037812
Neuropsychopharmacology. 2006 Jan;31(1):129-38
pubmed: 15920500
Behav Neurosci. 2016 Feb;130(1):50-61
pubmed: 26653713
Front Behav Neurosci. 2018 Jun 01;12:108
pubmed: 29910714
Pharmacol Biochem Behav. 2004 Jun;78(2):199-207
pubmed: 15219759
J Neurosci. 2011 Nov 30;31(48):17460-70
pubmed: 22131407
Exp Clin Psychopharmacol. 2005 Nov;13(4):311-8
pubmed: 16366761
Trends Pharmacol Sci. 2003 Nov;24(11):566-73
pubmed: 14607079
Physiol Behav. 2021 Feb 1;229:113260
pubmed: 33227243
J Neurosci. 2017 Nov 29;37(48):11537-11548
pubmed: 29079687
J Addict Med. 2014 Nov-Dec;8(6):399-406
pubmed: 25303980
Brain Res Cogn Brain Res. 2005 Apr;23(1):119-36
pubmed: 15795139
Learn Mem. 2007 Apr 27;14(5):325-8
pubmed: 17522022
Exp Neurol. 2014 Sep;259:64-74
pubmed: 24508560
Drug Alcohol Depend. 2002 Apr 1;66(2):161-71
pubmed: 11906803
Exp Clin Psychopharmacol. 2006 Feb;14(1):34-41
pubmed: 16503703
Drug Alcohol Depend. 1995 Jan;37(1):15-21
pubmed: 7882869
Pharmacol Biochem Behav. 2020 Sep;196:172994
pubmed: 32659242
Addict Biol. 2017 Jul;22(4):991-1001
pubmed: 27002211
Addict Biol. 2021 Nov;26(6):e13022
pubmed: 33559379
Psychopharmacology (Berl). 2014 Oct;231(21):4179-87
pubmed: 24728653
Neuron. 2011 Feb 24;69(4):650-63
pubmed: 21338877
Pharmacol Biochem Behav. 2018 Jan;164:118-124
pubmed: 28927583
Behav Brain Res. 2020 Feb 3;379:112386
pubmed: 31778734
Neurobiol Aging. 2017 Dec;60:141-152
pubmed: 28946018
Neurobiol Learn Mem. 2015 Jan;117:60-70
pubmed: 24642448
J Neurosci. 2011 Jun 22;31(25):9254-63
pubmed: 21697375
Drug Alcohol Depend. 2013 Sep 1;132(1-2):13-21
pubmed: 23623507
Behav Neurosci. 2010 Aug;124(4):470-7
pubmed: 20695646
Neuroimage. 2003 Jul;19(3):1085-94
pubmed: 12880834
Neuroimage. 2007 Mar;35(1):194-206
pubmed: 17236790
Nature. 2001 May 31;411(6837):583-7
pubmed: 11385572
Psychopharmacology (Berl). 2020 Jul;237(7):1893-1908
pubmed: 32363438
Eur J Neurosci. 2004 Apr;19(7):1997-2002
pubmed: 15078575
Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
pubmed: 8401595
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Mar 2;98:109791
pubmed: 31676462

Auteurs

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH